547 related articles for article (PubMed ID: 18430362)
21. Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
Peretti DE; Vállez García D; Reesink FE; van der Goot T; De Deyn PP; de Jong BM; Dierckx RAJO; Boellaard R
PLoS One; 2019; 14(1):e0211000. PubMed ID: 30653612
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
[TBL] [Abstract][Full Text] [Related]
23. Comparability of [
Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Wall A; Nordberg A
J Cereb Blood Flow Metab; 2017 Feb; 37(2):740-749. PubMed ID: 27107028
[TBL] [Abstract][Full Text] [Related]
24. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.
Lin KJ; Hsu WC; Hsiao IT; Wey SP; Jin LW; Skovronsky D; Wai YY; Chang HP; Lo CW; Yao CH; Yen TC; Kung MP
Nucl Med Biol; 2010 May; 37(4):497-508. PubMed ID: 20447562
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
Ziolko SK; Weissfeld LA; Klunk WE; Mathis CA; Hoge JA; Lopresti BJ; DeKosky ST; Price JC
Neuroimage; 2006 Oct; 33(1):94-102. PubMed ID: 16905334
[TBL] [Abstract][Full Text] [Related]
26. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
Rodriguez-Vieitez E; Carter SF; Chiotis K; Saint-Aubert L; Leuzy A; Schöll M; Almkvist O; Wall A; Långström B; Nordberg A
J Nucl Med; 2016 Jul; 57(7):1071-7. PubMed ID: 26912447
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.
Pan ML; Mukherjee MT; Patel HH; Patel B; Constantinescu CC; Mirbolooki MR; Liang C; Mukherjee J
Synapse; 2016 Apr; 70(4):163-76. PubMed ID: 26806100
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
Aalto S; Scheinin NM; Kemppainen NM; Någren K; Kailajärvi M; Leinonen M; Scheinin M; Rinne JO
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1651-60. PubMed ID: 19495749
[TBL] [Abstract][Full Text] [Related]
31. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C
Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669
[TBL] [Abstract][Full Text] [Related]
32. [Positron emission tomography imaging of cell transplantation in a rat model of Alzheimer's disease].
He TT; Zhang JM; Shen L; Yao SL; Tian JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):210-4. PubMed ID: 20450555
[TBL] [Abstract][Full Text] [Related]
33. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
[TBL] [Abstract][Full Text] [Related]
34. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
Yan L; Liu CY; Wong KP; Huang SC; Mack WJ; Jann K; Coppola G; Ringman JM; Wang DJJ
Neuroimage Clin; 2018; 17():751-760. PubMed ID: 29527482
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
36. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
37. Meta-analytic comparison between PIB-PET and FDG-PET results in Alzheimer's disease and MCI.
He W; Liu D; Radua J; Li G; Han B; Sun Z
Cell Biochem Biophys; 2015 Jan; 71(1):17-26. PubMed ID: 25370296
[TBL] [Abstract][Full Text] [Related]
38. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
Lockhart A; Lamb JR; Osredkar T; Sue LI; Joyce JN; Ye L; Libri V; Leppert D; Beach TG
Brain; 2007 Oct; 130(Pt 10):2607-15. PubMed ID: 17698496
[TBL] [Abstract][Full Text] [Related]
39. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
Klunk WE; Engler H; Nordberg A; Wang Y; Blomqvist G; Holt DP; Bergström M; Savitcheva I; Huang GF; Estrada S; Ausén B; Debnath ML; Barletta J; Price JC; Sandell J; Lopresti BJ; Wall A; Koivisto P; Antoni G; Mathis CA; Långström B
Ann Neurol; 2004 Mar; 55(3):306-19. PubMed ID: 14991808
[TBL] [Abstract][Full Text] [Related]
40. Applicability of [
Snellman A; Rokka J; López-Picón FR; Helin S; Re F; Löyttyniemi E; Pihlaja R; Forloni G; Salmona M; Masserini M; Solin O; Rinne JO; Haaparanta-Solin M
Neurobiol Aging; 2017 Sep; 57():84-94. PubMed ID: 28605642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
